OncoCyte's total assets for Q2 2024 were $74.72M, a decrease of -8.42% from the previous quarter. OCX total liabilities were $52.02M for the fiscal quarter, a 33.03% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.